The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2013

Filed:

Jun. 21, 2006
Applicants:

Meenakshi Sivakumar, Maharashtra, IN;

Malcolm Mascarenhas, Maharashtra, IN;

Ankush Sarde, Maharashtra, IN;

Pramod Kumar Jadhav, Maharashtra, IN;

Manoj Shukla, Maharastra, IN;

Kalpana Joshi, Maharashtra, IN;

Maggie Rathos, Maharashtra, IN;

Inventors:

Meenakshi Sivakumar, Maharashtra, IN;

Malcolm Mascarenhas, Maharashtra, IN;

Ankush Sarde, Maharashtra, IN;

Pramod Kumar Jadhav, Maharashtra, IN;

Manoj Shukla, Maharastra, IN;

Kalpana Joshi, Maharashtra, IN;

Maggie Rathos, Maharashtra, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/36 (2006.01); A61K 31/40 (2006.01); C07D 405/00 (2006.01); C07D 409/00 (2006.01); C07D 411/00 (2006.01); C07D 207/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to an enantiomerically pure (+)-trans enantiomer of a compound represented by the following formula (I): wherein R, R, R, Rand Rare as defined in the specification; enantiomerically pure intermediates thereof, to processes for the preparation of the enantiomerically pure compound and its intermediates, and to a pharmaceutical composition comprising the enantiomerically pure compound. The compound of formula (I) is useful for the treatment of diseases or disorders mediated by the inhibition of cyclin dependant kinase, such as cancer.


Find Patent Forward Citations

Loading…